Copyright Reports & Markets. All rights reserved.

Global Immuno-Cell Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Passive Immune (NK, LAK etc)
    • 1.2.3 Active Immune
  • 1.3 Market by Application
    • 1.3.1 Global Immuno-Cell Therapy Market Share by Application: 2020 VS 2026
    • 1.3.2 Oncology
    • 1.3.3 Cardiovascular Disease (CVD)
    • 1.3.4 Orthopedic
    • 1.3.5 Wound Healing
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Immuno-Cell Therapy Market Perspective (2015-2026)
  • 2.2 Global Immuno-Cell Therapy Growth Trends by Regions
    • 2.2.1 Immuno-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Immuno-Cell Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Immuno-Cell Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Immuno-Cell Therapy Players by Market Size
    • 3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Immuno-Cell Therapy Revenue
  • 3.4 Global Immuno-Cell Therapy Market Concentration Ratio
    • 3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2019
  • 3.5 Key Players Immuno-Cell Therapy Area Served
  • 3.6 Key Players Immuno-Cell Therapy Product Solution and Service
  • 3.7 Date of Enter into Immuno-Cell Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Cell Therapy Breakdown Data by Type (2015-2026)

  • 4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Immuno-Cell Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2015-2020)
  • 5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Immuno-Cell Therapy Market Size (2015-2026)
  • 6.2 North America Immuno-Cell Therapy Market Size by Type (2015-2020)
  • 6.3 North America Immuno-Cell Therapy Market Size by Application (2015-2020)
  • 6.4 North America Immuno-Cell Therapy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Immuno-Cell Therapy Market Size (2015-2026)
  • 7.2 Europe Immuno-Cell Therapy Market Size by Type (2015-2020)
  • 7.3 Europe Immuno-Cell Therapy Market Size by Application (2015-2020)
  • 7.4 Europe Immuno-Cell Therapy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Immuno-Cell Therapy Market Size (2015-2026)
  • 8.2 China Immuno-Cell Therapy Market Size by Type (2015-2020)
  • 8.3 China Immuno-Cell Therapy Market Size by Application (2015-2020)
  • 8.4 China Immuno-Cell Therapy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Immuno-Cell Therapy Market Size (2015-2026)
  • 9.2 Japan Immuno-Cell Therapy Market Size by Type (2015-2020)
  • 9.3 Japan Immuno-Cell Therapy Market Size by Application (2015-2020)
  • 9.4 Japan Immuno-Cell Therapy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Immuno-Cell Therapy Market Size (2015-2026)
  • 10.2 Southeast Asia Immuno-Cell Therapy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Immuno-Cell Therapy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Immuno-Cell Therapy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 MEDINET Co
    • 11.1.1 MEDINET Co Company Details
    • 11.1.2 MEDINET Co Business Overview
    • 11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
    • 11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2015-2020))
    • 11.1.5 MEDINET Co Recent Development
  • 11.2 Erytech
    • 11.2.1 Erytech Company Details
    • 11.2.2 Erytech Business Overview
    • 11.2.3 Erytech Immuno-Cell Therapy Introduction
    • 11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.2.5 Erytech Recent Development
  • 11.3 Seta Clinic Group
    • 11.3.1 Seta Clinic Group Company Details
    • 11.3.2 Seta Clinic Group Business Overview
    • 11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
    • 11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.3.5 Seta Clinic Group Recent Development
  • 11.4 Takeda
    • 11.4.1 Takeda Company Details
    • 11.4.2 Takeda Business Overview
    • 11.4.3 Takeda Immuno-Cell Therapy Introduction
    • 11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.4.5 Takeda Recent Development
  • 11.5 SBI Holdings
    • 11.5.1 SBI Holdings Company Details
    • 11.5.2 SBI Holdings Business Overview
    • 11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
    • 11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.5.5 SBI Holdings Recent Development
  • 11.6 Oxford BioTherapeutics
    • 11.6.1 Oxford BioTherapeutics Company Details
    • 11.6.2 Oxford BioTherapeutics Business Overview
    • 11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
    • 11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.6.5 Oxford BioTherapeutics Recent Development
  • 11.7 Fate Therapeutics
    • 11.7.1 Fate Therapeutics Company Details
    • 11.7.2 Fate Therapeutics Business Overview
    • 11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
    • 11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.7.5 Fate Therapeutics Recent Development
  • 11.8 Gilead Sciences
    • 11.8.1 Gilead Sciences Company Details
    • 11.8.2 Gilead Sciences Business Overview
    • 11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
    • 11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.8.5 Gilead Sciences Recent Development
  • 11.9 Novartis
    • 11.9.1 Novartis Company Details
    • 11.9.2 Novartis Business Overview
    • 11.9.3 Novartis Immuno-Cell Therapy Introduction
    • 11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.9.5 Novartis Recent Development
  • 11.10 Osiris
    • 11.10.1 Osiris Company Details
    • 11.10.2 Osiris Business Overview
    • 11.10.3 Osiris Immuno-Cell Therapy Introduction
    • 11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 11.10.5 Osiris Recent Development
  • 11.11 Vericel Corporation
    • 10.11.1 Vericel Corporation Company Details
    • 10.11.2 Vericel Corporation Business Overview
    • 10.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
    • 10.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 10.11.5 Vericel Corporation Recent Development
  • 11.12 Fujifilm Cellular Dynamics
    • 10.12.1 Fujifilm Cellular Dynamics Company Details
    • 10.12.2 Fujifilm Cellular Dynamics Business Overview
    • 10.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
    • 10.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 10.12.5 Fujifilm Cellular Dynamics Recent Development
  • 11.13 JCR Pharmaceuticals
    • 10.13.1 JCR Pharmaceuticals Company Details
    • 10.13.2 JCR Pharmaceuticals Business Overview
    • 10.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
    • 10.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 10.13.5 JCR Pharmaceuticals Recent Development
  • 11.14 Beike Biotechnology
    • 10.14.1 Beike Biotechnology Company Details
    • 10.14.2 Beike Biotechnology Business Overview
    • 10.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
    • 10.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 10.14.5 Beike Biotechnology Recent Development
  • 11.15 Golden Meditech
    • 10.15.1 Golden Meditech Company Details
    • 10.15.2 Golden Meditech Business Overview
    • 10.15.3 Golden Meditech Immuno-Cell Therapy Introduction
    • 10.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 10.15.5 Golden Meditech Recent Development
  • 11.16 Guanhao Biotech
    • 10.16.1 Guanhao Biotech Company Details
    • 10.16.2 Guanhao Biotech Business Overview
    • 10.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
    • 10.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 10.16.5 Guanhao Biotech Recent Development
  • 11.17 Beroni Group
    • 10.17.1 Beroni Group Company Details
    • 10.17.2 Beroni Group Business Overview
    • 10.17.3 Beroni Group Immuno-Cell Therapy Introduction
    • 10.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2015-2020)
    • 10.17.5 Beroni Group Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Immuno-Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immuno-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Passive Immune (NK, LAK etc)
    Active Immune

    Market segment by Application, split into
    Oncology
    Cardiovascular Disease (CVD)
    Orthopedic
    Wound Healing
    Others

    Based on regional and country-level analysis, the Immuno-Cell Therapy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Immuno-Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    MEDINET Co
    Erytech
    Seta Clinic Group
    Takeda
    SBI Holdings
    Oxford BioTherapeutics
    Fate Therapeutics
    Gilead Sciences
    Novartis
    Osiris
    Vericel Corporation
    Fujifilm Cellular Dynamics
    JCR Pharmaceuticals
    Beike Biotechnology
    Golden Meditech
    Guanhao Biotech
    Buy now